In Silico Modeling of Non-Linear Drug Absorption for the P-gp Substrate Talinolol and of Consequences for the Resulting Pharmacodynamic Effect

In Silico Modeling of Non-Linear Drug Absorption for the P-gp Substrate Talinolol and of Consequences for the Resulting Pharmacodynamic Effect

Publication: AAPS J
Software: GastroPlus®
Division: PBPK

The aim of the present work was to demonstrate P-glycoprotein's involvement in the non-linear talinolol pharmacokinetics using an advanced compartment and transit model (ACAT) and to compare...

Inhibition of the NF-kappaB pathway by varicella-zoster virus in vitro and in human epidermal cells in vivo

Inhibition of the NF-kappaB pathway by varicella-zoster virus in vitro and in human epidermal cells in vivo

Authors: Jones JO, Arvin AM
Publication: J Virol
Division: PBPK

Varicella-zoster virus (VZV) is an alphaherpesvirus that causes varicella and herpes zoster. Using human cellular DNA microarrays, we found that many nuclear factor kappa B...

NIPALSTREE:  A New Hierarchical Clustering Approach for Large Compound Libraries and Its Application to Virtual Screening

NIPALSTREE:  A New Hierarchical Clustering Approach for Large Compound Libraries and Its Application to Virtual Screening

Publication: J Chem Inf Model
Software: MedChem Studio™

A hierarchical clustering algorithm NIPALSTREE was developed that is able to analyze large data sets in high-dimensional space. The result can be displayed as a dendrogram.

Are Target-Family-Privileged Substructures Truly Privileged?

Are Target-Family-Privileged Substructures Truly Privileged?

Publication: J Med Chem
Software: MedChem Studio™

One of the early and effective approaches to G-coupled protein receptor target family library design was the analysis of a set of ligands for frequently occurring chemical moieties or substructures.

A strategy for preclinical formulation development using GastroPlus™ as pharmacokinetic simulation tool and a statistical screening design applied to a dog study.

A strategy for preclinical formulation development using GastroPlus™ as pharmacokinetic simulation tool and a statistical screening design applied to a dog study.

Publication: Eur J Pharm Sci
Software: GastroPlus®

The aim of this paper is to propose a pharmaceutical risk assessment strategy that goes beyond the usual characterisation of a clinical candidate molecule according to the biopharmaceutical classification system (BCS).

Comparison of censored regression and standard regression analyses for modeling relationships between antimicrobial susceptibility and patient- and institution-specific variables

Comparison of censored regression and standard regression analyses for modeling relationships between antimicrobial susceptibility and patient- and institution-specific variables

Publication: Antimicrob Agents Chemother

In order to identify patients likely to be infected with resistant bacterial pathogens, analytic methods such as standard regression (SR) may be applied to surveillance data to determine patient- and institution-specific...

Challenges in the transition to model-based development

Challenges in the transition to model-based development

Publication: AAPS J

Practitioners of the art and science of pharmacometrics are well aware of the considerable effort required to successfully complete modeling and simulation activities...

Antimicrobial safety: focus on fluoroquinolones

Antimicrobial safety: focus on fluoroquinolones

Authors: Owens RC, Ambrose PG
Publication: Clin Infect Dis

Infrequent toxicities associated with certain drugs and drug classes have recently gained much attention from different health-care perspectives.

Classifying “Kinase Inhibitor‐Likeness” by Using Machine‐Learning Methods

Classifying “Kinase Inhibitor‐Likeness” by Using Machine‐Learning Methods

Authors: Briem H, Gunther J
Publication: Chembiochem
Software: MedChem Studio™

By using an in-house data set of small-molecule structures, encoded by Ghose–Crippen parameters, several machine learning techniques were applied to distinguish between kinase inhibitors...

Application of Full Physiological Models for Pharmaceutical Drug Candidate Selection and Extrapolation of Pharmacokinetics to Man

Application of Full Physiological Models for Pharmaceutical Drug Candidate Selection and Extrapolation of Pharmacokinetics to Man

Publication: Basic Clin Pharmacol Toxicol
Software: GastroPlus®

This paper describes how we are applying physiologically based models of pharmacokinetics as an integrated part in the research and preclinical development of novel drugs.